Loading…
Quality Care for Moms and Babies Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
53pct
8d open
vs 7,393 other HR bills in the 115th — cohort avg 50d
Quality Care for Moms and Babies Act This bill directs the Centers for Medicare & Medicaid Services (CMS) to: identify and publish a recommended core set of maternal and infant quality measures for women and children, as specified by the bill; publish an initial core set of any such measures applicable to mothers and infants eligible under Medicaid or the Children's Health Insurance Program (CHIP); establish a Maternal and Infant Quality Measurement Program; and establish an online clearinghouse of resources for entities working to improve maternity and infant care quality. The CMS may make grants to eligible entities for: the development of new state and regional maternity and infant care quality collaboratives, expanded activities of existing collaboratives, and maternity and infant care initiatives within established state and regional quality collaboratives that are not focused exclusively on maternity care. Under current law, the CMS must contract with a consensus-based entity to carry out specified duties regarding performance measurement. The bill requires such an entity to facilitate increased coordination and alignment between the public and private sector with respect to quality and efficiency measures.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2018 · fourth_quarter · Health Issues
Preventing Maternal Deaths Act (HR 1318), Maternal Health Accountability Act (S. 1112), pre-term birth, maternal mental health, Quality Care for Moms and Babies Act (S. 2367/HR 5457), Improving Access to Maternity Care Act (S. 783, HR 315); PREEMIE Reauthorization (S. 3029/HR 6085); MOMMA's Act (HR 5977); Ending Maternal Mortality Act (HR 5761); pregnancy research.
Referred to the Subcommittee on Human Resources.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $20,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
2018 · fourth_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of reconciliation legislation, see BUD (Budget/Appropriations) page. For activity pertaining to other health-care reform ("Obamacare replacement") legislation, see HCR (Health Issues) page. Contacts in support of the Dismemberment Abortion Ban Act (H.R. 1192, Smith), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (H.R. 4660, S. 2326), to prohibit discrimination against the unborn on the basis of sex or race. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 4712, S. 220), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the House dated January 16, 2018, and a letter to the House on Rule resolution H. Res. 694 dated January 17, 2018. (The House passed the bill on January 17, 2018.) Contacts in support of the No Taxpayer Funding for Abortion Act (H.R. 7, S. 184), including letter to House dated January 19, 2017, to codify government-wide policy against funding abortion (passed House January 24, 2017). Contacts in support of Child Interstate Abortion Notification Act (CIANA)(H.R.692, S. 224), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of the Conscience Protection Act (H.R. 644, S. 301), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of Women's Public Health and Safety Act (H.R. 656), to allow a state to exclude certain abortion providers from participation in the state's Medicaid program. Consultations regarding various bills intended to tighten federal limitations on trafficking in tissue from induced abortions (including H.R. 524, H.R. 1203, H.R. 1895, and other draft bills not introduced); no specific legislation endorsed during this quarter. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of The Protecting the Dignity of Unborn Children Act (H.R. 718), to make it a federal crime to dispose of non-cremated "fetal remains" (from abortions) in a landfill or navigable waterway. Contacts in response to inquiries regarding the Heartbeat Bill (H.R.490) to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "Women's Health Protection Act" (H.R. 1322, S. 510), a proposed federal statute to invalidate virtually all state and federal regulations pertaining to abortion. Contacts in opposition to "EACH Woman Act" (H.R. 771), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Patients First Act (H.R. 2918) to require the federal National Institutes of Health to intensify research on types of stem-cell research that do not involve harming human embryos. Responses to inquiries regarding "Life at Conception Act" (H.R. 681, S. 231); nonsupport due to lack of clarity and erroneous legal premises. Contracts regarding abortion-pill reversal and informed consent requirements. Legislation not introduced. Contacts regarding the Maternal Health Accountability Act (S. 1112 and H.R. 1318), related to reporting factors, contract grantee criteria, and potential issues surrounding recommending expansion of abortion access. No position taken this quarter. Contacts in support of a letter requesting that HHS issue new Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts regarding the Protecting Health and Wellness of Babies and Pregnant Women in Custody Act (H.R. 6085) as related to potential issues regarding abortion. No position taken this quarter.   Contacts regarding the Quality Care for Moms and Babies Act (S.2637/H.R.5457) as related to potential issues regarding abortion. No position taken this quarter. Supported veto and sustaining of veto of any bill that weakens any existing pro-life policy.  
Client expense: $80,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · fourth_quarter · Health Issues
Health Insurance Coverage (general); Health Disparities (general); Breastfeeding (general); Assisted Reproductive Technology (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Intimate Partner Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Conscience Refusals (general); Child Welfare (general); Prematurity (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Contraception (general); National Health Service Corps (general); Abortion (general); Hyde Amendment (General); Indian Health (general); Teaching Health Centers (general); Teen Pregnancy Prevention Program (general); Personal Responsibility Education Program (general); Research in Pregnant and Breastfeeding Women (general); Health Care Reform (general); Title X (general); Womens Preventive Services (general); H.R. 5457/S. 2637, Quality Care for Moms and Babies Act; H.R. 1318/S 1112, Preventing Maternal Deaths Act/Maternal Health Accountability Act; H.R. 5977/S. 3776, MOMMAs Act; H.R.5761, Ending Maternal Mortality Act of 2018; S. 3392, MOMs Act; S. 3363, Maternal CARE Act; S.3494, MOMMIES Act; S. 3568, Rural MOMS Act; H.R. 1876/S. 781, Good Samaritan Health Professionals Act; S.2852/H.R. 6378 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; S. 783, Improving Access to Maternity Care Act; H.R. 3602/S. 1653, Real Education for Healthy Youth Act; H.R. 6085/S. 3029, the PREEMIE Reauthorization Act; H.R. 4993/S.3253, Vaccine Access Improvement Act of 2018; P.L. 115-271, SUPPORT for Patients and Communities Act; H.R. 6805, Pregnant Women in Custody Act; S. 756, First Step Act; S. 2960 Access to Infertility Treatment and Care Act; H.J.Res. 140/S.J.Res. 63, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Department of the Treasury, Department of Labor, and the Department of Health and Human Services relating to Short-Term, Limited Duration Insurance; Implementation of P.L. 114-91, Protecting Our Infants Act; Implementation of P.L. 114-198, Comprehensive Addiction and Recovery Act; Implementation of P.L. 114-255, 21st Century Cures Act; H.R. 6545, Violence Against Women Reauthorization Act.
Client expense: $202,071 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
2018 · third_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of reconciliation legislation, see BUD (Budget/Appropriations) page. For activity pertaining to other health-care reform ("Obamacare replacement") legislation, see HCR (Health Issues) page. Contacts in support of the Dismemberment Abortion Ban Act (H.R. 1192, Smith), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (H.R. 4660, S. 2326), to prohibit discrimination against the unborn on the basis of sex or race. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 4712, S. 220), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the House dated January 16, 2018, and a letter to the House on Rule resolution H. Res. 694 dated January 17, 2018. (The House passed the bill on January 17, 2018.) Contacts in support of the No Taxpayer Funding for Abortion Act (H.R. 7, S. 184), including letter to House dated January 19, 2017, to codify government-wide policy against funding abortion (passed House January 24, 2017). Contacts in support of Child Interstate Abortion Notification Act (CIANA)(H.R.692, S. 224), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of the Conscience Protection Act (H.R. 644, S. 301), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of Women's Public Health and Safety Act (H.R. 656), to allow a state to exclude certain abortion providers from participation in the state's Medicaid program. Consultations regarding various bills intended to tighten federal limitations on trafficking in tissue from induced abortions (including H.R. 524, H.R. 1203, H.R. 1895, and other draft bills not introduced); no specific legislation endorsed during this quarter. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of The Protecting the Dignity of Unborn Children Act (H.R. 718), to make it a federal crime to dispose of non-cremated "fetal remains" (from abortions) in a landfill or navigable waterway. Contacts in response to inquiries regarding the Heartbeat Bill (H.R.490) to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "Women's Health Protection Act" (H.R. 1322, S. 510), a proposed federal statute to invalidate virtually all state and federal regulations pertaining to abortion. Contacts in opposition to "EACH Woman Act" (H.R. 771), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Patients First Act (H.R. 2918) to require the federal National Institutes of Health to intensify research on types of stem-cell research that do not involve harming human embryos. Responses to inquiries regarding "Life at Conception Act" (H.R. 681, S. 231); nonsupport due to lack of clarity and erroneous legal premises. Contracts regarding abortion-pill reversal and informed consent requirements. Legislation not introduced. Contacts regarding the Maternal Health Accountability Act (S. 1112 and H.R. 1318), related to reporting factors, contract grantee criteria, and potential issues surrounding recommending expansion of abortion access. No position taken this quarter. Contacts in support of a letter requesting that HHS issue new Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts regarding the Protecting Health and Wellness of Babies and Pregnant Women in Custody Act (H.R. 6085) as related to potential issues regarding abortion. No position taken this quarter.   Contacts regarding the Quality Care for Moms and Babies Act (S.2637/H.R.5457) as related to potential issues regarding abortion. No position taken this quarter.  
Client expense: $80,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · third_quarter · Health Issues
Preventing Maternal Deaths Act (HR 1318), Maternal Health Accountability Act (S. 1112), pre-term birth, maternal mental health, Quality Care for Moms and Babies Act (S. 2367/HR 5457), Improving Access to Maternity Care Act (S. 783, HR 315); PREEMIE Reauthorization (S. 3029/HR 6085); MOMMA's Act (HR 5977); Ending Maternal Mortality Act (HR 5761); pregnancy research.
Client expense: $20,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
2018 · third_quarter · Health Issues
Health Insurance Coverage (general); Health Disparities (general); Breastfeeding (general); Assisted Reproductive Technology (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Intimate Partner Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Conscience Refusals (general); Child Welfare (general); Prematurity (general); Health Disparities (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Lab Developed Tests (general); Contraception (general); Preeclampsia (general); Over the Counter Drugs (general); National Health Service Corps (general); Community Health Centers (general); Abortion (general); Hyde Amendment (General); Indian Health (general); Teaching Health Centers (general); Teen Pregnancy Prevention Program (general); Research in Pregnant and Breastfeeding Women (general); Healthy Start (general); Health Care Reform (general); Title X (general); Personal Responsibility Education Program (general); Womens Preventive Services (general); H.R. 5457/S. 2637, Quality Care for Moms and Babies Act; H.R. 1318/S 1112, Preventing Maternal Deaths Act/Maternal Health Accountability Act; H.R. 5977, MOMMAs Act; H.R.5761, Ending Maternal Mortality Act of 2018; S. 3392, MOMs Act; S. 3363, Maternal CARE Act; S.3494, MOMMIES Act; H.R. 1876/S. 781, Good Samaritan Health Professionals Act; S.2852/H.R. 6378 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; S. 783, Improving Access to Maternity Care Act; S.Res. 605, A resolution designating the first week in August as World Breastfeeding Week, and designating August as National Breastfeeding Month; H.R. 3602/S. 1653, Real Education for Healthy Youth Act; H.R. 421/S. 93, Allowing Greater Access to Safe and Effective Contraception Act; H.R. 6085/S. 3029, the PREEMIE Reauthorization Act; H.R. 3692, Addiction Treatment Access Improvement Act; S. 2680, Opioid Crisis Response Act; H.R. 5818/S. 2843, the Opioid Workforce Act of 2018; H.R. 2501/S. 1148, CRIB Act; H.R. 4993/ S.3253 - Vaccine Access Improvement Act of 2018; H.R. 6, SUPPORT for Patients and Communities Act; H.R. 6805, Pregnant Women in Custody Act; S. 2960 Access to Infertility Treatment and Care Act; H.J.Res. 140/S.J.Res. 63, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Department of the Treasury, Department of Labor, and the Department of Health and Human Services relating to Short-Term, Limited Duration Insurance; Implementation of P.L. 114-91, Protecting Our Infants Act; Implementation of P.L. 114-198, Comprehensive Addiction and Recovery Act; Implementation of P.L. 114-255, 21st Century Cures Act; H.R. 6545/S.___, Violence Against Women Reauthorization Act.
2018 · second_quarter · Health Issues
Preventing Maternal Deaths Act (HR 1318), Maternal Health Accountability Act (S. 1112), pre-term birth, maternal mental health, Quality Care for Moms and Babies Act (S. 2367/HR 5457), Improving Access to Maternity Care Act (S. 783, HR 315); PREEMIE Reauthorization (S. 3029/HR 6085); MOMMA's Act (HR 5977); Ending Maternal Mortality Act (HR 5761); pregnancy research.
Client expense: $20,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
2018 · second_quarter · Health Issues
Health Insurance Coverage (general); Genetic Screening and Testing (general); Health Disparities (general); Breastfeeding (general); Pregnancy Intention (general); Assisted Reproductive Technology (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Intimate Partner Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Conscience Refusals (general); Child Welfare (general); Prematurity (general); Health Disparities (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Lab Developed Tests (general); Stem Cell Research (general); Contraception (general); Preeclampsia (general); Drug Pricing (general); Over the Counter Drugs (general); National Health Service Corps (general); Community Health Centers (general); Abortion (general); Hyde Amendment (General); Indian Health (general);; Teaching Health Centers (general); ; Teen Pregnancy Prevention Program (general); Research in Pregnant and Breastfeeding Women (general); Healthy Start (general); Zika Virus (general); Health Care Reform (general); Title X (general); Personal Responsibility Education Program (general); Womens Preventive Services (general); H.R. 5457/S. 2637, Quality Care for Moms and Babies Act; H.R. 1318/S 1112, Preventing Maternal Deaths Act/Maternal Health Accountability Act; H.R. ___, MOMMAs Act; H.R.5761 - Ending Maternal Mortality Act of 2018; H.R. 1876/S. 781, Good Samaritan Health Professionals Act; H.R. 1215/S.___ Protecting Access to Care Act; H.R. 1565, Saving Lives, Saving Costs Act; S.2852/H.R. 6378 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; H.R. 3120, To amend title XVIII of the Social Security Act to reduce the volume of future electronic health record-related significant hardship requests; S. 783, Improving Access to Maternity Care Act; ; H.R. 3602/S. 1653, Real Education for Healthy Youth Act; H.R. 421/S. 93, Allowing Greater Access to Safe and Effective Contraception Act; ; H.R. 6085/S. 3029, the PREEMIE Reauthorization Act; H.R. 3692, Addiction Treatment Access Improvement Act; H.R. 5272, Reinforcing Evidence-Based Standards Under Law in Treating Substance Abuse Act; S. 2680, Opioid Crisis Response Act; H.R. 5562, Protecting NAS Babies Act; H.R. 2501/S. 1148, CRIB Act; H.R.___ Medicaid Partnership Act; H.R.___ To amend title XIX of the Social Security Act to provide for a demonstration project to increase substance use provider capacity under the Medicaid program; H.R. 3192, CHIP Mental Health Parity Act; H.R. ___, Incentivizing Non-Opioid Drugs; H.R. 6, SUPPORT for Patients and Communities Act; S. 3120, HEAL Act; S. 1113, Personal Care Products Safety Act; S. ___, Bipartisan Heath Care Stabilization Act; H.Res. 818/S.Res.459, Recognizing Black Maternal Health Week to bring national attention to the maternal health care crisis in the Black community and the importance of reducing the rate of maternal mortality and morbidity among Black Women; H. ___, Diagnostic Accuracy and Innovation Act (DAIA); S. 2960 Access to Infertility Treatment and Care Act; H.R.___/S.___ Violence Against Women Act; Implementation of P.L. 114-91, Protecting Our Infants Act; Implementation of P.L. 114-198, Comprehensive Addiction and Recovery Act; Implementation of P.L. 114-255, 21st Century Cures Act.
2018 · first_quarter · Health Issues
Preventing Maternal Deaths Act (HR 1318/), Maternal Health Accountability Act (S. 1112), pre-term birth, maternal mental health, Quality Care for Moms and Babies Act (S. 2367/HR 5457), Improving Access to Maternity Care Act (S. 783, HR 315); pregnancy research.
Client expense: $20,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
2018 · first_quarter · Health Issues
Health Insurance Coverage (general); Genetic Screening and Testing (general); Health Disparities (general); Emergency Contraception (general); Breastfeeding (general); Pregnancy Intention (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Domestic Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Conscience Refusals (general); Child Welfare (general); Prematurity (general); Health Disparities (general); Maternal Mortality and Morbidity (general); Imaging (general); Graduate Medical Education (general); Lab Developed Tests (general); Stem Cell Research (general); Contraception (general); Preeclampsia (general); National Health Service Corps (general); Community Health Centers (general); Abortion (general); Indian Health (general); Opioid Epidemic (general); Teaching Health Centers (general); H.R.3394/S. 1754, Teaching Health Centers Graduate Medical Education Extension Act of 2017/Training the Next Generation of Primary Care Doctors Act of 2017; Teen Pregnancy Prevention Program (general); Research in Pregnant and Breastfeeding Women (general); Healthy Start (general); Zika Virus (general); Health Care Reform (general); H.R. 5457/S. 2637, Quality Care for Moms and Babies Act; H.R. 1318/S 1112, Preventing Maternal Deaths Act/Maternal Health Accountability Act; H.R. ___, Kiras Law; H.R. 1876/S. 781, Good Samaritan Health Professionals Act; H.R. 1215/S.___ Protecting Access to Care Act; H.R. 1565, Saving Lives, Saving Costs Act; H.R. 3120, To amend title XVIII of the Social Security Act to reduce the volume of future electronic health record-related significant hardship requests; H.R. 315/S. 783, Improving Access to Maternity Care Act; Hyde Amendment (General); H.R. 671/ S. 210, the Global Health Empowerment and Rights (Global HER) Act; HR 4418, the Enhancing Questions to Understand Intentions for Pregnancy (EQUIP) Act of 2017; H.R. 3602/S. 1653, Real Education for Healthy Youth Act; H.R. 421/S. 93, Allowing Greater Access to Safe and Effective Contraception Act; H. Res. 205, expressing the sense of the House of Representatives with respect to ensuring that womens health care under current law is preserved; H.R. 2567/ S. 2259, Access to Birth Control (ABC) Act; H.R. 4082/S. 1985, Protect Access to Birth Control Act; S. 1045, Save Womens Preventive Care Act; H.R. 490, Heartbeat Protection Act; H.R. 36/S. 2311, Pain-Capable Unborn Child Protection Act; HR 4712, Born-Alive Abortion Survivors Protection Act; H.R. 3842, Healthy Start Reauthorization Act; H.R.__/S. ___, the PREEMIE Reauthorization Act; H.R. 3692, Addiction Treatment Access Improvement Act; H.R. 253/S. 1268, Family First Prevention Services Act/Child Protection and Family Support Act; H.R. 2545/S. 747, Special Diabetes Program for Indians Reauthorization Act; S. 1113, Personal Care Products Safety Act; Personal Responsibility Education Program (general); Womens Preventive Services (general); S. ___, Bipartisan Heath Care Stabilization Act; H.Res. 403/S.Res. 451, Supporting the designation of March 2018 as Endometriosis Awareness Month; Implementation of P.L. 114-91, Protecting Our Infants Act; Implementation of P.L. 114-198, Comprehensive Addiction and Recovery Act; Implementation of P.L. 114-255, 21st Century Cures Act.
| Democratic |
| MN |
| David P. Roe | Republican | TN |
| Debbie Dingell | Democratic | MI |
| Debbie Wasserman Schultz | Democratic | FL |
| Don Young | Republican | AK |
| Doris O. Matsui | Democratic | CA |
| Earl Blumenauer | Democratic | OR |
| John A. Yarmuth | Democratic | KY |
| John Garamendi | Democratic | CA |
| Lucille Roybal-Allard | Democratic | CA |
| Mark Pocan | Democratic | WI |
| Michelle Lujan Grisham | Democratic | NM |
| Peter T. King | Republican | NY |
| Ro Khanna | Democratic | CA |
| Steve Cohen | Democratic | TN |
| Steve Stivers | Republican | OH |
| Tony Cárdenas | Democratic | CA |
| Zoe Lofgren | Democratic | CA |
Client expense: $190,590 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
Client expense: $361,427 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
Client expense: $553,520 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office